Interestingly, the stimulator of interferon genes (STING) pathway, which results in APC activation, production of IFN-β and priming of CD8 T cells against tumor antigens was shown to be critical for synergistic anti-tumor effects of anti PD-1 and anti-CTLA-4 [96]. The gene discussed is CTLA4; the disease is neoplasm.